Burning Rock Biotech Ltd. ADR (BNR) News
Filter BNR News Items
BNR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest BNR News From Around the Web
Below are the latest news stories about Burning Rock Biotech Ltd that investors may wish to consider to help them evaluate BNR as an investment opportunity.
Yacktman Fund Buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Associated British ...Investment company Yacktman Fund (Current Portfolio) buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Associated British Foods PLC, Samsung Electronics Co, Hyundai Motor Co, sells Brenntag SE, Macy's Inc, The Walt Disney Co, Stanley Electric Co during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Yacktman Fund. |
Yacktman Focused Fund Buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Hyundai ...Investment company Yacktman Focused Fund (Current Portfolio) buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Hyundai Motor Co, Yuasa Trading Co, Hyundai Motor Co, sells Brenntag SE, The Walt Disney Co, Macy's Inc, First Hawaiian Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Yacktman Focused Fund. |
Burning Rock Reaffirms 2021 Revenue Guidance of RMB500 MillionGUANGZHOU, China, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that, based on the latest operating trends, the Company expects its 2021 revenue to be at or slightly above RMB500 million. The Company is pleased with the recent progress achieved, despite elevated COVID impact that has been ongoing since the beginning of November, including the first diagnosed Omicron case in China and increased lock-downs in December. |
Burning Rock Announces Results of 2021 Annual General MeetingGUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that all shareholder resolutions proposed at the Company’s 2021 annual general meeting held today were duly passed. Specifically, the shareholders passed the following resolutions approving: the ratification of the appointment of Ernst |
Analysts Anticipate Burning Rock Biotech Limited (NASDAQ:BNR) Will Post Earnings of $0.12 Per ShareBrokerages forecast that Burning Rock Biotech Limited (NASDAQ:BNR) will announce earnings per share (EPS) of $0.12 for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Burning Rock Biotechs earnings. Burning Rock Biotech posted earnings of ($0.23) per share in the same quarter last year, which suggests a positive year-over-year growth [] |
Franklin International Equity Fund Buys L'Oreal SA, Compagnie Financiere Richemont SA, Airbus ...Investment company Franklin International Equity Fund (Current Portfolio) buys L'Oreal SA, Compagnie Financiere Richemont SA, Airbus SE, Electricite de France SA, SSE PLC, sells Sanofi SA, Brenntag SE, Randstad NV, Marubeni Corp, Holcim during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Franklin International Equity Fund. |
Burning Rock Biotech Limited (NASDAQ:BNR) Short Interest Down 19.8% in NovemberBurning Rock Biotech Limited (NASDAQ:BNR) was the recipient of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 1,660,000 shares, a decrease of 19.8% from the October 31st total of 2,070,000 shares. Currently, 1.9% of the companys stock are sold short. Based on an [] |
Burning Rock Biotech (NASDAQ:BNR) Sets New 52-Week Low at $11.74Burning Rock Biotech Limited (NASDAQ:BNR)s share price reached a new 52-week low on Friday . The company traded as low as $11.74 and last traded at $11.83, with a volume of 8258 shares changing hands. The stock had previously closed at $12.98. A number of research firms have weighed in on BNR. Zacks Investment Research [] |
Burning Rock Biotech (NASDAQ:BNR) Lowered to Strong Sell at Zacks Investment ResearchZacks Investment Research lowered shares of Burning Rock Biotech (NASDAQ:BNR) from a hold rating to a strong sell rating in a research note released on Tuesday morning, Zacks.com reports. According to Zacks, Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of [] |
Burning Rock Biotech (NASDAQ:BNR) Shares Down 5.1%Burning Rock Biotech Limited (NASDAQ:BNR)s stock price dropped 5.1% during mid-day trading on Monday . The stock traded as low as $16.27 and last traded at $16.27. Approximately 4,040 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 330,318 shares. The stock had previously closed at $17.14. BNR [] |